6小时乳酸清除率及降钙素原对脓毒症患者预后的评估价值

李亚红, 乔鲁军, 张建, 等. 6小时乳酸清除率及降钙素原对脓毒症患者预后的评估价值[J]. 临床急诊杂志, 2015, 16(12): 950-953. doi: 10.13201/j.issn.1009-5918.2015.12.015
引用本文: 李亚红, 乔鲁军, 张建, 等. 6小时乳酸清除率及降钙素原对脓毒症患者预后的评估价值[J]. 临床急诊杂志, 2015, 16(12): 950-953. doi: 10.13201/j.issn.1009-5918.2015.12.015
LI Yahong, QIAO Lujun, ZHANG Jian, et al. Evaluation of the prognosis of patients with sepsis by 6 hours arterial blood lactate clearance and PCT[J]. J Clin Emerg, 2015, 16(12): 950-953. doi: 10.13201/j.issn.1009-5918.2015.12.015
Citation: LI Yahong, QIAO Lujun, ZHANG Jian, et al. Evaluation of the prognosis of patients with sepsis by 6 hours arterial blood lactate clearance and PCT[J]. J Clin Emerg, 2015, 16(12): 950-953. doi: 10.13201/j.issn.1009-5918.2015.12.015

6小时乳酸清除率及降钙素原对脓毒症患者预后的评估价值

详细信息
    通讯作者: 乔鲁军,E-mail:qiaolujun@medmail.com.cn
  • 中图分类号: R631

Evaluation of the prognosis of patients with sepsis by 6 hours arterial blood lactate clearance and PCT

More Information
  • 目的:探讨动脉血乳酸清除率、降钙素原(PCT)与脓毒症患者预后的评估价值。方法:回顾性分析2011-10-2014-10入住我院重症医学科的120例脓毒症患者临床资料,入院24 h内行PCT及初始乳酸(入科时监测)和6 h的血乳酸水平监测,计算6 h乳酸清除率、APACHEⅡ评分,并比较死亡组患者和存活组患者乳酸清除率、PCT及APACHEⅡ评分的差异,比较不同APACHEⅡ评分分层组间PCT及6 h乳酸清除率的差异,对APACHEⅡ评分、PCT、6 h乳酸清除率进行相关性分析;绘制受试者工作特征曲线(ROC);评价PCT、6 h乳酸清除率对脓毒症患者预后的评估价值。结果:死亡组患者入院时PCT、APACHEⅡ评分明显高于存活组患者,6 h乳酸清除率明显低于存活组,差异有统计学意义(P<0.01);乳酸清除率、PCT在不同APACHEⅡ评分分层组间两两比较差异均有统计学意义(P<0.01);经过Spearman相关性分析入院患者6 h血乳酸清除率与APACHEⅡ评分呈显著负相关(P<0.01),且随着APACHEⅡ评分的升高,动脉血6 h乳酸清除率明显降低,PCT与APACHEⅡ评分呈显著正相关(P<0.01)。6 h乳酸清除率预测患者28 d病死率的ROC曲线下面积(AUC)为0.93±0.03(95%CI:0.87~0.99),截断值为18.64%,灵敏度82.86%,特异度95.56%,Youden指数0.784;PCT预测患者28 d病死率的AUC为0.79±0.05(95%CI:0.68~0.89),截断值为7.78 ng/ml,灵敏度79.41%,特异度70.37%,Youden指数0.498。结论:动脉血血乳酸清除率联合PCT可作为判断脓毒症患者病情和预后的重要监测指标。
  • 加载中
  • [1]

    Arnold R C,Shapiro N I,Jones A E,et al.Mult icent er study of early lact at e clearance as a det erminant of survival in pat ients with presumed sepsis[J].Shock,2009,32:35-39.

    [2]

    周雄,胥志跃,范江花,等.危重症患儿血乳酸水平与病情的关系[J].中国当代儿科杂志,2012,14(2):114-116.

    [3]

    崔书章,寿松涛,柴艳芬.实用危重病医学[M].天津:天津科学技术出版社,2001:913-920.

    [4]

    王今达,王宝恩.MODS病情分期诊断及严重程度评分标准[J].中国危重病急救医学,1995,7(6):346-346.

    [5]

    邹龚,邹颋,李峰,等.APACHEⅡ评分系统在危重患者抢救中的应用[J].江西医学院学报,2006,46(5):143-144.

    [6]

    Nguyen H B,Rivers E P,Knoblich B P,et al.Early laelate clearance is associated with improved outcome in severe sepsis and septic shock[J].Crit Care Med,2004,32:1637-1642.

    [7]

    时兢、宋秀琴、俞亚芬,等.降钙素原和C-反应蛋白对脓毒症的诊断价值比较[J].临床急诊杂志,2004,5(5):7-8.

    [8]

    降钙素原急诊临床应用专家共识组.降钙素原(PCT)急诊临床应用的专家识[J].中华急诊医学杂志,2012,21(9):944-951.

    [9]

    Jansen T C,Van Bommel J,Bakke J.Blood lactate monitoring in critic-ally ill patients:a systematic health technology assessment[J].Crit Care Med,2009,37:2827-2839.

    [10]

    Saboltzki A,Muhling J,Czesliek E.Sepsis and multiple organ failure-Update of current therapeutic concepts[J].Anasthessiol Intensived Notfallmed Schmerzther,2005,40(9):511-520.

    [11]

    林书生,高勃,姜平,等.ICU危重患者血乳酸变化水平与预后的关系探讨[J].临床急诊杂志,2013,1(14):20-23.

    [12]

    Naved S A,Siddiqui S,Khan F H.APACHEⅡ score correlation w ithmortality and length of st ay in an int ensive care unit[J].J Coll Physicians Surg Pak,2011,21:4-8.

    [13]

    Jeon E J,Jung J W,Choi J C,et al.The value of procalcitonin and the SAPS Ⅱ and APACHEⅢ scores in the dif ferentiation of infect ious and non-infectious f ever in the ICU:a prospect ive,cohort study[J].J Korean Med Sci,2010,25:1633-1637.

  • 加载中
计量
  • 文章访问数:  171
  • PDF下载数:  547
  • 施引文献:  0
出版历程
收稿日期:  2015-07-16

目录